HEPA OTC
Hepion Pharmaceuticals, Inc.
1W: -7.3%
1M: +14.0%
3M: +2.5%
YTD: +35.0%
1Y: +76.1%
3Y: -100.0%
5Y: -100.0%
$0.08
-0.02 (-19.00%)
Weekly Expected Move ±41.9%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$4M
+78.5% ▲
Net Income
-$8M
+37.3% ▲
EPS (Diluted)
$-0.88
+99.2% ▲
EBITDA
-$8M
+44.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $20M | $33M | $36M | $12M | $446K |
| SG&A Expenses | $10M | $10M | $10M | $7M | $3M |
| Operating Expenses | $30M | $45M | $48M | $19M | $4M |
| Operating Income | -$30M | -$45M | -$48M | -$19M | -$4M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $9K | $10K | $9K | $1M | $24K |
| Income Before Tax | -$33M | -$45M | -$49M | -$16M | -$8M |
| Tax Expense | $0 | -$3M | -$409K | -$3M | $0 |
| Net Income | -$33M | -$42M | -$49M | -$13M | -$8M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-465.52 | $-594.75 | $-616.07 | $-107.35 | $-0.88 |
| EBITDA | -$33M | -$45M | -$49M | -$15M | -$8M |
| Shares Outstanding | 70291 | 76229 | 79416 | 122894 | 9M |